Kyle Watters
Director, Precision Editing Arbor Biotechnologies
Kyle Watters, Director of Discovery Platform at Arbor Biotechnologies, leads early platform development focused on next-generation genome editing technologies. His work centers on advancing novel CRISPR-based tools and editing modalities to expand target accessibility and enable increasingly precise genomic modifications. Kyle’s team is dedicated to developing innovative in vivo editing approaches, with the goal of unlocking new therapeutic possibilities for rare genetic diseases.
Seminars
Wednesday 30th September 2026
Delivering Prime Editing Within AAV to Unlock Precise In Vivo Gene Editing
11:15 am
- Showcasing how prime and RT editing technologies can be packaged within AAV to give you insight into a uniquely precise approach to in vivo gene editing
- Unpacking the engineering challenges of fitting prime editing systems within AAV size constraints to help you understand the innovations enabling this delivery approach
- Highlighting how AAV-delivered prime editing compares to conventional CRISPR approaches to equip you with a broader perspective on next-generation in vivo editing options
